Renal-cell carcinoma--molecular pathways and therapies
- PMID: 17215538
- DOI: 10.1056/NEJMe068263
Renal-cell carcinoma--molecular pathways and therapies
Comment on
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Clinical Trial.
-
Sorafenib in advanced clear-cell renal-cell carcinoma.N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655. N Engl J Med. 2007. PMID: 17215530 Clinical Trial.
Similar articles
-
Sunitinib, sorafenib and mTOR inhibitors in renal cancer.J BUON. 2007 Sep;12 Suppl 1:S151-62. J BUON. 2007. PMID: 17935273 Review.
-
[Molecular targeted therapy for renal cell carcinoma].Rinsho Ketsueki. 2008 Aug;49(8):622-5. Rinsho Ketsueki. 2008. PMID: 18800611 Review. Japanese. No abstract available.
-
[Role of VEGFR-TKIs in the treatment of renal cell carcinoma].Nihon Jinzo Gakkai Shi. 2012;54(5):574-80. Nihon Jinzo Gakkai Shi. 2012. PMID: 22991835 Review. Japanese. No abstract available.
-
New therapeutic approaches in the management of metastatic renal cell carcinoma.J BUON. 2009 Jul-Sep;14(3):399-404. J BUON. 2009. PMID: 19810129 Review.
-
Signaling inhibitors in metastatic renal cell carcinoma.Cancer J. 2008 Sep-Oct;14(5):325-9. doi: 10.1097/PPO.0b013e3181867605. Cancer J. 2008. PMID: 18836338
Cited by
-
PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review).Exp Ther Med. 2021 May;21(5):540. doi: 10.3892/etm.2021.9972. Epub 2021 Mar 23. Exp Ther Med. 2021. PMID: 33815613 Free PMC article. Review.
-
The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Clin Exp Metastasis. 2014 Jan;31(1):111-34. doi: 10.1007/s10585-013-9612-7. Clin Exp Metastasis. 2014. PMID: 23959576 Review.
-
Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.Oncotarget. 2014 Nov 15;5(21):10280-92. doi: 10.18632/oncotarget.2163. Oncotarget. 2014. PMID: 25373733 Free PMC article. Clinical Trial.
-
Genetic diversity and selection of Tibetan sheep breeds revealed by whole-genome resequencing.Anim Biosci. 2023 Jul;36(7):991-1002. doi: 10.5713/ab.22.0432. Epub 2023 May 2. Anim Biosci. 2023. PMID: 37170524 Free PMC article.
-
A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma.Oncotarget. 2017 Sep 23;8(50):87773-87781. doi: 10.18632/oncotarget.21206. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152119 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous